Bird & Bird advises sellers on Arlane's majority acquisition of Dessintey

Bird & Bird advised the sellers, including the founders and Relyens Innovation Santé, while Volt Associés advised Arlane in connection with Arlane's acquisition of a majority stake in Dessintey. The transaction concerns Arlane taking a majority shareholding in Dessintey, a company that designs, assembles and distributes neuromotor rehabilitation devices and intelligent rehabilitation pathways for patients with neurological disorders such as stroke and traumatic brain injury. Dessintey markets its own devices and third‑party products for several European manufacturers and provides maintenance services. Founded in 2017 and employing 17 people, Dessintey has equipped more than 150 centres in France and across Europe (including Spain, Germany, Belgium, Italy and the Nordic countries), as well as in Asia and the United States. Having established itself as a reference player in motor and cognitive rehabilitation, the group has experienced strong growth and forecasts revenue of €10 million in 2025. Going forward, Dessintey intends to accelerate organic growth in France and internationally, broaden its product range, strengthen its foreign distribution network and is exploring potential external growth opportunities to support expansion. Bird & Bird represented the sellers (including the founders and Relyens Innovation Santé) with a team composed by: Felicien Bardsley, associate; and Inès Louguar, collaborator. Volt Associés represented Arlane with a team composed by: Emmanuel Vergnaud, associate; Stéphane Letranchant, associate; Gontran Souweine, collaborator; Antoine Lhomme, collaborator; Gamliel Senoussi, collaborator; Julien Humas, collaborator; Maïa Rideau, collaborator; and Morgane Le Gallic, collaborator.

Bird & Bird advises sellers on Arlane's majority acquisition of Dessintey

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads